VF Corp Posts Strong Q3 but Stock Drops on Tariff Concerns
VF Corporation beats Q3 revenue estimates with $2.88B sales, but warns of $100M tariff impact. North Face and Timberland grow 8%, while Vans struggles with 8% decline.
VF Corporation beats Q3 revenue estimates with $2.88B sales, but warns of $100M tariff impact. North Face and Timberland grow 8%, while Vans struggles with 8% decline.
Piper Sandler begins coverage of Shattuck Labs with an Overweight rating and $15 target, highlighting promise of SL-325 ahead of Phase 1 data.
CalciMedica discontinues Phase 2 KOURAGE trial for acute kidney injury drug Auxora following safety concerns raised by independent committee monitoring the study.
Glaukos receives FDA approval allowing patients to receive multiple iDose TR treatments for glaucoma management, expanding treatment options.
Mizuho upgrades Circle Internet to Neutral with $77 price target, citing USDC activity on Polymarket as a key growth catalyst.
Palladyne AI shares jumped 47% premarket after winning an Air Force contract to coordinate autonomous systems including satellites using its SwarmOS platform.